Skip to main content
. 2011 Jul 27;8:26. doi: 10.1186/1742-6405-8-26

Figure 2.

Figure 2

Frequency of common mutations. The percentage of therapies which developed mutation during therapy at the indicated location (top), and which had a preexisting mutation at the indicated location (bottom), by risk group. The patterns are consistent across the different risk groups. Locations are codons which were mutant at the start of 5% or more of the therapies, but which are not included on the International AIDS Society list of resistance mutations [18].